{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:42:08Z","timestamp":1780879328913,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.autrev.2012.02.021","type":"journal-article","created":{"date-parts":[[2012,3,6]],"date-time":"2012-03-06T02:40:20Z","timestamp":1331001620000},"page":"852-855","source":"Crossref","is-referenced-by-count":40,"title":["Malignancies associated with systemic sclerosis"],"prefix":"10.1016","volume":"11","author":[{"given":"\u00c9va","family":"Szekanecz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szilvia","family":"Szamosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gnes","family":"Horv\u00e1th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1gnes","family":"N\u00e9meth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bal\u00e1zs","family":"Juh\u00e1sz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e1nos","family":"Sz\u00e1nt\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Sz\u00fccs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Szekanecz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.autrev.2012.02.021_bb0005","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.autrev.2006.03.007","article-title":"Malignancies and soluble tumor antigens in rheumatic diseases","volume":"6","author":"Szekanecz","year":"2006","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.autrev.2012.02.021_bb0010","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.autrev.2009.07.004","article-title":"Malignancies in systemic lupus erythematosus","volume":"9","author":"Kiss","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.autrev.2012.02.021_bb0015","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.autrev.2009.07.002","article-title":"Secondary tumours in Sjogren's syndrome","volume":"9","author":"Kovacs","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2012.02.021_bb0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000314634","article-title":"Malignancies in autoimmune rheumatic diseases\u2014a mini-review","volume":"57","author":"Szekanecz","year":"2011","journal-title":"Gerontology"},{"issue":"1","key":"10.1016\/j.autrev.2012.02.021_bb0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/ard.2006.066340","article-title":"Survival and causes of death in 366 Hungarian patients with systemic sclerosis","volume":"67","author":"Czirjak","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2012.02.021_bb0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/01.bor.0000209423.39033.94","article-title":"Malignancy and autoimmunity","volume":"18","author":"Bernatsky","year":"2006","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2012.02.021_bb0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00002281-200301000-00007","article-title":"Rheumatic syndromes associated with malignancy","volume":"15","author":"Chakravarty","year":"2003","journal-title":"Curr Opin Rheumatol"},{"issue":"10","key":"10.1016\/j.autrev.2012.02.021_bb0040","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1136\/ard.2004.033241","article-title":"Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists","volume":"64","author":"Askling","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2012.02.021_bb0045","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/art.1780360405","article-title":"Cancer in systemic sclerosis","volume":"36","author":"Abu-Shakra","year":"1993","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.autrev.2012.02.021_bb0050","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s10067-008-0925-x","article-title":"Incidence of lymphoma in systemic sclerosis: a retrospective analysis of 218 Hungarian patients with systemic sclerosis","volume":"27","author":"Szekanecz","year":"2008","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2012.02.021_bb0055","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/SMJ.0b013e31815838ce","article-title":"Systemic sclerosis and malignancy: a review of the literature","volume":"101","author":"Wooten","year":"2008","journal-title":"South Med J"},{"issue":"6","key":"10.1016\/j.autrev.2012.02.021_bb0060","first-page":"1113","article-title":"A cohort study of cancer incidence in systemic sclerosis","volume":"33","author":"Derk","year":"2006","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2012.02.021_bb0065","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/art.1780281204","article-title":"Cancer and systemic sclerosis. An epidemiologic study","volume":"28","author":"Roumm","year":"1985","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2012.02.021_bb0070","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1136\/ard.2007.085852","article-title":"Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register","volume":"68","author":"Askling","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.autrev.2012.02.021_bb0075","first-page":"1705","article-title":"Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases","volume":"26","author":"Asten","year":"1999","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2012.02.021_bb0080","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00296-008-0540-9","article-title":"Breast cancer and systemic sclerosis: a clinical description of 21 patients in a population-based cohort study","volume":"28","author":"Lu","year":"2008","journal-title":"Rheumatol Int"},{"issue":"4","key":"10.1016\/j.autrev.2012.02.021_bb0085","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1136\/ard.2006.056424","article-title":"Risk factors for lung cancer in patients with scleroderma: a nested case\u2013control study","volume":"66","author":"Pontifex","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.autrev.2012.02.021_bb0090","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/ard.62.8.728","article-title":"Risk of cancer in patients with scleroderma: a population based cohort study","volume":"62","author":"Hill","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.autrev.2012.02.021_bb0095","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1002\/art.21225","article-title":"Risk of malignancy in scleroderma: a population-based cohort study","volume":"52","author":"Chatterjee","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2012.02.021_bb0100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/106689690601400108","article-title":"Malignant lymphoma in patients with systemic rheumatic disease (rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, and dermatomyositis): a clinicopathologic study of 24 Japanese cases","volume":"14","author":"Kojima","year":"2006","journal-title":"Int J Surg Pathol"},{"issue":"6","key":"10.1016\/j.autrev.2012.02.021_bb0105","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s10067-004-0940-5","article-title":"Association between systemic sclerosis and breast cancer: eight new cases and review of the literature","volume":"23","author":"Launay","year":"2004","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2012.02.021_bb0110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S1368-8375(03)00137-4","article-title":"Primary B-cell lymphoma of the tongue in a patient with systemic sclerosis","volume":"40","author":"Derk","year":"2004","journal-title":"Oral Oncol"},{"issue":"1","key":"10.1016\/j.autrev.2012.02.021_bb0115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jbspin.2005.01.009","article-title":"Systemic sclerosis and gastric MALT lymphoma","volume":"73","author":"Arnaud","year":"2006","journal-title":"Joint Bone Spine"},{"issue":"6","key":"10.1016\/j.autrev.2012.02.021_bb0120","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/BOR.0b013e32834a5081","article-title":"Cancer and systemic sclerosis: novel insights into pathogenesis and clinical implications","volume":"23","author":"Shah","year":"2011","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2012.02.021_bb0125","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.autrev.2008.02.001","article-title":"Rheumatic disorders as paraneoplastic syndromes","volume":"7","author":"Racanelli","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.autrev.2012.02.021_bb0130","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/archinternmed.2007.107","article-title":"Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis","volume":"168","author":"Bernatsky","year":"2008","journal-title":"Arch Intern Med"},{"issue":"1A","key":"10.1016\/j.autrev.2012.02.021_bb0135","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0002-9343(85)90245-1","article-title":"Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment","volume":"78","author":"Kinlen","year":"1985","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.autrev.2012.02.021_bb0140","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0002-9343(99)80160-0","article-title":"Hematologic malignancies and the use of methotrexate in rheumatoid arthritis: a retrospective study","volume":"99","author":"Moder","year":"1995","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2012.02.021_bb0145","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00296-011-2321-0","article-title":"Systemic sclerosis and malignancies after cyclophosphamide therapy: a single center experience","volume":"32","author":"Isik","year":"2012","journal-title":"Rheumatol Int"},{"issue":"12","key":"10.1016\/j.autrev.2012.02.021_bb0150","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.autrev.2010.07.011","article-title":"Biologics\u2014beyond the joints","volume":"9","author":"Szekanecz","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.autrev.2012.02.021_bb0155","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1136\/ard.2008.093690","article-title":"Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research","volume":"68","author":"Salliot","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.autrev.2012.02.021_bb0160","first-page":"838","article-title":"Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease","volume":"20","author":"Silver","year":"1993","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2012.02.021_bb0165","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee","volume":"23","year":"1980","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2012.02.021_bb0170","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1196\/annals.1422.008","article-title":"Occurrence of malignancies in Hungarian patients with systemic lupus erythematosus: results from a single center","volume":"1108","author":"Tarr","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2012.02.021_bb0175","first-page":"99","article-title":"Trends in cancer mortality and morbidity in Hungarian and international statistics","volume":"49","author":"Szabolcs","year":"2005","journal-title":"Hung Oncol"},{"key":"10.1016\/j.autrev.2012.02.021_bb0180","first-page":"4","article-title":"Secondary malignancies in systemic sclerosis","volume":"50","author":"Szekanecz","year":"2009","journal-title":"Hung Rheumatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997212000493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997212000493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,25]],"date-time":"2018-11-25T08:55:56Z","timestamp":1543136156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997212000493"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S1568997212000493"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2012.02.021","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}